Form 4 for PALI PALISADE BIO, INC.
Accepted 2023-09-29 00:00:00 ET · period of report 2023-09-27 · accession 0001493152-23-034754 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-29 | 2023-09-27 | PALI | Finley John David | CEO, CFO, Dir | P - Purchase | $0.54 | +15.0K | 43.4K | +53% | +$8,100 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2023-09-27 | P | A | 15,000 | $0.54 | 43,394 | D | — | — | (F1) Reporting Person purchased 15,000 shares of Common Stock of Issuer at a price per share of $0.5392 on September 27, 2023. |